Misconceptions about influenza vaccination
- Underlying illness
“You have to have underlying illness to benefit from the vaccine.”
Riga Conference: proceedings submission deadline extended
23 March 2015
All speakers who contributed to the Fifth ESWI Influenza Conference’s outstanding scientific programme are kindly invited to submit their research paper to the corresponding special issue of Vaccine. The Fifth ESWI Influenza Conference Special Issue of Vaccine will feature original research articles and review articles. It will be published online in September 2015.
The deadline for submissions is extended until 30 April 2015. The submission website for this journal is located here.
To ensure that all manuscripts are correctly identified, it is important to select “SI: 5th ESWI Influenza Conference” when you reach the “Article Type” step in the submission process.
Science Policy Flu Summit: 30 September 2015
12 February 2015
ESWI and EPHA are looking forward to organizing the Science Policy Flu Summit on 30 September 2015 in the European Quarter in Brussels. The aim of the one-day meeting is to bring together public health officials and decision-makers and to provide them with a platform to exchange information and ideas, to meet scientists and other members of the Flu Community and to keep track of the latest scientific data with respect to influenza.
30 January 2015
New analysis of efficacy data confirms that timely administration of the antiviral influenza drug oseltamivir considerably reduces the impact of an influenza infection in adults. The study results have now been published in The Lancet. Click here for the full article.